MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 766.83
-8.38 (-1.08%)
At close: Aug 25, 2026
MINAPHARM Pharmaceuticals Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,649 | 3,430 | 2,885 | 1,918 | 1,694 | 981.94 |
Short-Term Investments | - | - | 5 | - | - | - |
Cash & Short-Term Investments | 3,649 | 3,430 | 2,890 | 1,918 | 1,694 | 981.94 |
Cash Growth | 33.32% | 18.66% | 50.70% | 13.25% | 72.47% | -4.06% |
Accounts Receivable | 934.67 | 509.58 | 647.52 | 492.9 | 478.14 | 388.76 |
Other Receivables | 0.98 | 0.99 | 5.83 | 46.13 | 12.22 | 5.52 |
Receivables | 1,153 | 654.72 | 934.67 | 742.76 | 575.06 | 399.59 |
Inventory | 1,676 | 1,495 | 1,233 | 1,055 | 838.28 | 668.51 |
Prepaid Expenses | 77.11 | 41.07 | 30.33 | 10.76 | 12.41 | 6.54 |
Other Current Assets | 663.39 | 632.51 | 629.14 | 315.92 | 524.8 | 345.77 |
Total Current Assets | 7,219 | 6,253 | 5,717 | 4,042 | 3,644 | 2,402 |
Property, Plant & Equipment | 6,512 | 6,154 | 5,687 | 4,251 | 2,685 | 1,340 |
Long-Term Investments | - | 5 | - | 5 | 5 | 5 |
Goodwill | 383.36 | 355.35 | 339.97 | 334.51 | 280.08 | 220.53 |
Other Intangible Assets | 398.92 | 375.91 | 254.84 | 67.1 | 56.9 | 48.2 |
Long-Term Deferred Tax Assets | - | - | 7.02 | - | - | - |
Other Long-Term Assets | 5.78 | 5.22 | 4.92 | 3.22 | 134.67 | 89.77 |
Total Assets | 14,518 | 13,148 | 12,010 | 8,704 | 6,806 | 4,106 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,450 | 1,191 | 1,222 | 707.54 | 677.29 | 416.64 |
Accrued Expenses | 95.64 | 109.9 | 47.34 | 46.81 | 39.23 | 31.53 |
Short-Term Debt | 1,769 | 2,021 | 2,312 | 2,071 | 1,042 | 542.29 |
Current Portion of Long-Term Debt | 803.29 | 706.58 | 398.09 | 218.67 | 225.33 | 32.93 |
Current Portion of Leases | 55.26 | 49.42 | 55.35 | 27.77 | 15.1 | 68.13 |
Current Income Taxes Payable | 310.64 | 255.06 | 195.94 | 134.82 | 233.36 | 183.69 |
Current Unearned Revenue | 20.06 | 17.25 | 14.62 | 9.81 | 7.45 | 5.04 |
Other Current Liabilities | 552.05 | 457.44 | 495.28 | 314.7 | 261.3 | 208.89 |
Total Current Liabilities | 5,055 | 4,807 | 4,740 | 3,531 | 2,501 | 1,489 |
Long-Term Debt | 2,077 | 1,503 | 2,250 | 1,335 | 1,036 | 603.87 |
Long-Term Leases | 271.83 | 260.05 | 562.68 | 153.62 | 114.83 | 1.17 |
Long-Term Unearned Revenue | 250.4 | 194.97 | 167.5 | - | - | - |
Long-Term Deferred Tax Liabilities | 9.27 | 24.86 | - | 44.99 | 56.01 | 22.69 |
Other Long-Term Liabilities | - | - | - | 121.15 | 57.52 | 45.73 |
Total Liabilities | 7,664 | 6,790 | 7,720 | 5,186 | 3,765 | 2,163 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 117.81 | 117.81 | 117.81 | 122.93 | 122.93 | 122.93 |
Retained Earnings | 4,153 | 4,086 | 1,934 | 2,147 | 2,023 | 1,466 |
Treasury Stock | - | - | - | -69.63 | -69.63 | - |
Comprehensive Income & Other | 2,455 | 2,047 | 2,135 | 1,222 | 882.83 | 293.27 |
Total Common Equity | 6,726 | 6,251 | 4,187 | 3,423 | 2,959 | 1,882 |
Minority Interest | 128.96 | 107.76 | 102.74 | 94.61 | 81.82 | 61.29 |
Shareholders' Equity | 6,855 | 6,358 | 4,290 | 3,517 | 3,041 | 1,943 |
Total Liabilities & Equity | 14,518 | 13,148 | 12,010 | 8,704 | 6,806 | 4,106 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,976 | 4,540 | 5,578 | 3,806 | 2,433 | 1,248 |
Net Cash (Debt) | -1,327 | -1,110 | -2,688 | -1,889 | -739.64 | -266.46 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -119.90 | -100.33 | -242.93 | -170.70 | -64.46 | -21.67 |
Filing Date Shares Outstanding | 11.78 | 11.78 | 11.78 | 11.06 | 11.06 | 12.29 |
Total Common Shares Outstanding | 11.78 | 11.78 | 11.78 | 11.06 | 11.06 | 12.29 |
Working Capital | 2,163 | 1,446 | 976.61 | 511.26 | 1,143 | 913.2 |
Book Value Per Share | 570.91 | 530.56 | 355.43 | 309.35 | 267.42 | 153.07 |
Tangible Book Value | 5,944 | 5,519 | 3,592 | 3,021 | 2,622 | 1,613 |
Tangible Book Value Per Share | 504.51 | 468.49 | 304.94 | 273.05 | 236.96 | 131.21 |
Land | 62.99 | 57.96 | 55.2 | 39.7 | 33.23 | 26.15 |
Buildings | 1,783 | 1,701 | 1,579 | 508.65 | 411.79 | 296.6 |
Machinery | 3,535 | 3,246 | 2,505 | 1,777 | 1,365 | 977.94 |
Construction In Progress | 3,092 | 2,924 | 2,988 | 2,936 | 1,666 | 666.97 |